These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3197226)

  • 1. [Effects of sodium ferulate on platelet aggregation and platelet thromboxane A2 in patients with coronary heart disease].
    Gao SW; Chen ZJ
    Zhong Xi Yi Jie He Za Zhi; 1988 May; 8(5):263-5, 259. PubMed ID: 3197226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on mechanism of the antiplatelet effect of sodium ferulate--effect on TXA2/PGI2 balance].
    Xu LN; Xu DC; Zhang BJ; Wang RL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):414-7. PubMed ID: 6242542
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of sodium ferulate combined with acetylsalicylic acid on rat platelet aggregation and on modulation of PGI2-TXA2 balance].
    Xu LN; Wang RL; Xu DC
    Yao Xue Xue Bao; 1985 Jan; 20(1):5-9. PubMed ID: 3895824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sodium ferulate is an inhibitor of thromboxane A2 synthetase].
    Wang Z; Gao YH; Huang RS; Zhu GQ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):430-3. PubMed ID: 3218538
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of sodium ferulate on C14-arachidonic acid metabolism in rabbit platelets].
    Xu LN; Yu WG; Tian JY
    Zhong Xi Yi Jie He Za Zhi; 1988 Oct; 8(10):614-5, 583. PubMed ID: 3255545
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy in coronary heart disease.
    Frishman WH
    Hosp Pract (Hosp Ed); 1982 May; 17(5):73-86. PubMed ID: 7044945
    [No Abstract]   [Full Text] [Related]  

  • 7. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

  • 9. [Increased adhesive and aggregation activity of the platelets of ischemic heart disease patients with stable stenocardia].
    Sinitsyn VE; Mazurov AV; Liakishev AA; Sidorenko BA; Repin VS
    Kardiologiia; 1987 Feb; 27(2):96-7. PubMed ID: 3573534
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet functions and factor VIII Ag in coronary heart disease.
    Yu GR; Xie GY; Huang MX; Zhong DS; Xie XL
    Chin Med J (Engl); 1987 Feb; 100(2):116-7. PubMed ID: 3109837
    [No Abstract]   [Full Text] [Related]  

  • 11. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina.
    Mehta J; Mehta P; Ostrowski N
    J Lab Clin Med; 1985 Dec; 106(6):661-6. PubMed ID: 2866219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of sodium ferulate on malondialdehyde production from the platelets of rats].
    Yin ZZ; Wang JP; Xu LN
    Zhongguo Yao Li Xue Bao; 1986 Jul; 7(4):336-9. PubMed ID: 2954394
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet activity in acute and chronic ischemic heart disease, with reference to the type of hyperlipoproteinemia.
    Stăncioiu N; Scrobohaci ML; Zătreanu I; Orha I
    Med Interne; 1978; 16(4):395-403. PubMed ID: 749178
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the filtration pressure of the platelet aggregates in a group of coronary patients].
    Pagnan A; Donadon W; Barbieri E; Tonolli E; Dal Palù C
    Boll Soc Ital Cardiol; 1976; 21(6):696-80. PubMed ID: 1031066
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboxane A2 synthesizing activity of platelets in coronary artery diseases.
    Yamazaki H; Kawagoe S; Yamaguchi A; Munakata J; Kuroki S; Tanoue K
    Jpn Circ J; 1987 Apr; 51(4):451-8. PubMed ID: 3613046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased platelet aggregation but increased thromboxane A2 generation in polycythemia vera.
    Mehta P; Mehta J; Ross M; Ostrowski N; Player D
    Arch Intern Med; 1985 Jul; 145(7):1225-7. PubMed ID: 4015270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented platelet reactivity and thromboxane A2 production possible aggravating factors in unstable angina.
    Tada M; Hoshida S; Kuzuya T
    Jpn Circ J; 1986 Feb; 50(2):181-7. PubMed ID: 3723780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the level of polyunsaturated fatty acids, substrates and inhibitors of thromboxane and prostacyclin synthesis, in the blood of patients with cardiovascular diseases].
    Mevkh AT; Ius'kovich AK; Duzhenko VS; Li ED; Lakin KM
    Kardiologiia; 1990 Sep; 30(9):54-7. PubMed ID: 2273739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.